K
Kang Hoe Lee
Researcher at Gleneagles Hospital
Publications - 8
Citations - 1333
Kang Hoe Lee is an academic researcher from Gleneagles Hospital. The author has contributed to research in topics: T cell & Cytotoxic T cell. The author has an hindex of 8, co-authored 8 publications receiving 1197 citations.
Papers
More filters
Journal ArticleDOI
The role of virus-specific CD8+ cells in liver damage and viralcontrol during persistent hepatitis B virus infection
Mala K. Maini,Carolina Boni,Kang Hoe Lee,J.R. Larrubia,S. Reignat,Graham S. Ogg,Jethro Herberg,RJ Gilson,Akeel Alisa,Roger Williams,Diego Vergani,Nikolai V. Naoumov,Carlo Ferrari,Antonio Bertoletti +13 more
TL;DR: In this paper, the role of cytotoxic T cells in the pathogenesis of hepatitis B virus (HBV) infection was investigated. And the authors showed that in the presence of an effective HBV-specific CD8 response, inhibition of virus replication can be independent of liver damage.
Journal ArticleDOI
IL-7 Licenses Activation of Human Liver Intrasinusoidal Mucosal-Associated Invariant T Cells
Xin-Zi Tang,Juandy Jo,Anthony T. Tan,Elena Sandalova,Adeline Chia,K.C. Tan,Kang Hoe Lee,Adam J. Gehring,Gennaro De Libero,Gennaro De Libero,Antonio Bertoletti +10 more
TL;DR: Analysis of MAIT cells resident in the vascular bed of livers showed that they represented the majority of T cells expressing NK markers and the dominant IL-17A+ T cell subset in the human liver sinusoids, and it was shown that IL-7, a cytokine produced by hepatocytes during inflammation, regulated TCR-mediated activation ofMAIT cells, licensing them to dramatically increase Th1 cytokines and IL- 17A production.
Journal ArticleDOI
Inflammatory tumour microenvironment is associated with superior survival in hepatocellular carcinoma patients
Valerie Chew,Charlene Tow,Marissa Teo,Hing Lok Wong,Jasmine Chan,Adam J. Gehring,Marie Loh,Alexandre Bolze,Richard Quek,Victor Kwan Min Lee,Kang Hoe Lee,Jean-Pierre Abastado,Han Chong Toh,Alessandra Nardin +13 more
TL;DR: An inflammatory immune microenvironment within HCC tumours could be an important means to control tumour progression via TIL activation and proliferation.
Journal ArticleDOI
Toll-like receptor 8 agonist and bacteria trigger potent activation of innate immune cells in human liver.
Juandy Jo,Anthony T. Tan,James E. Ussher,Elena Sandalova,Xin-Zi Tang,Alfonso Tan-Garcia,Natalie To,Michelle Hong,Adeline Chia,Upkar S. Gill,Patrick T F Kennedy,K.C. Tan,Kang Hoe Lee,Gennaro De Libero,Adam J. Gehring,Christian B. Willberg,Paul Klenerman,Antonio Bertoletti +17 more
TL;DR: The human liver harbors a network of immune cells able to modulate their immunological responses to different pathogen-associated molecules, and their ability to generate a strong production of IFN-γ upon stimulation with TLR8 agonist opens new therapeutic opportunities for the treatment of diverse liver pathologies.
Journal ArticleDOI
Profile of tumor antigen-specific CD8 T cells in patients with hepatitis B virus-related hepatocellular carcinoma.
Adam J. Gehring,Zi Zong Ho,Anthony T. Tan,Myat Oo Aung,Kang Hoe Lee,K.C. Tan,Seng Gee Lim,Antonio Bertoletti,Antonio Bertoletti +8 more
TL;DR: Patients with or without HCC have a quantitative and functional hierarchy of tumor-specific T cells, and HLA-A2-restricted T cells from HCC patients exist in an exhausted state that might require additional activation to restore function.